Talphera (TLPH) Cash from Financing Activities (2010 - 2026)
Talphera (TLPH) recorded quarterly Cash from Financing Activities of $4.0 million in Q1 2026, up 188.17% quarter-over-quarter from $1.4 million in Q4 2025, and up 80960.0% on a YoY basis from N/an in Q1 2025.
Talphera (TLPH) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Talphera's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 80960.0% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $26.8 million (up 107052.0% YoY), while the FY2025 annual figure was $22.7 million, up 88.81% from the prior year.
- Cash from Financing Activities was $4.0 million for Q1 2026 at Talphera, up from $1.4 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $17.0 million in Q3 2025 to a low of -$3.3 million in Q2 2023.
- Historically, Cash from Financing Activities has averaged $2.8 million across 5 years, with a median of $30000.0 in 2024.
- The sharpest annual moves came in 2022 and 2026: Cash from Financing Activities plunged 106.09% in 2022, then soared 80960.0% in 2026.
- A 5-year view of Cash from Financing Activities shows it stood at $5.3 million in 2022, then tumbled by 101.28% to -$68000.0 in 2023, then soared by 144.12% to $30000.0 in 2024, then jumped by 4576.67% to $1.4 million in 2025, then surged by 188.17% to $4.0 million in 2026.
- The last three Cash from Financing Activities figures came in at $4.0 million (Q1 2026), $1.4 million (Q4 2025), and $17.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 13.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -840.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.48 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -86.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -65.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.47 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -77.88 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -11.62 Mn |
| 10 | Talphera | 56.42 Mn | 56.42 Mn | - | 4.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.04 Mn |
| Mar 31, 2026 | 4.04 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 16.99 Mn |
| Sep 30, 2025 | 16.99 Mn |
| Jun 30, 2025 | 4.35 Mn |
| Jun 30, 2025 | 4.35 Mn |
| Mar 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Sep 30, 2024 | 30,000.00 |
| Mar 31, 2024 | 12.01 Mn |
| Mar 31, 2024 | 12.01 Mn |
| Dec 31, 2023 | -68,000.00 |
| Dec 31, 2023 | -68,000.00 |
| Sep 30, 2023 | 8.94 Mn |
| Sep 30, 2023 | 8.94 Mn |
| Jun 30, 2023 | -3.33 Mn |
| Jun 30, 2023 | -3.33 Mn |